相关实验视频

Updated: Jul 25, 2025

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

瘤微环境作为黑色素瘤治疗中的治疗标

Naji Kharouf^1,2, Thomas W Flanagan³, Sofie-Yasmin Hassan⁴

¹Biomaterials and Bioengineering, Institut National de la Santé et de la Recherche Médicale, Université de Strasbourg, Unité Mixte de Recherche 1121, 67000 Strasbourg, France.

|June 28, 2023

概括

瘤微环境显著影响黑色素瘤的生长和治疗耐药性. 针对这些微环境组件,为黑色素瘤提供了一个有希望的治疗策略.

科学领域:

在瘤学瘤学.
癌症生物学癌症生物学

背景情况:

瘤微环境 (TME) 在瘤进展,维护和治疗耐药性方面发挥着关键作用.
TME的组成部分,包括树突细胞,细胞外基质 (ECM) 和可溶性分子,影响瘤细胞的行为.
黑色素瘤是一种固体瘤,涉及瘤细胞与周围微环境之间的复杂相互作用.

研究的目的:

审查TME组件在调节黑色素瘤进展中的多方面的作用.
探索TME如何促进黑色素瘤的治疗耐药性.
讨论将TME作为黑色素瘤治疗策略的潜在目标.

主要方法:

关于黑色素瘤瘤微环境现有研究的文献综述.
关于黑色素瘤细胞和TME组件之间的相互作用的证据综合.
针对黑色素瘤中TME的治疗策略的分析.

主要成果:

TME对于黑色素瘤细胞的生存,增殖和转移至关重要.
特定的TME成分,如免疫细胞和细胞外基质,促进瘤生长和免疫逃避.
移动肌瘤是黑色素瘤对常规疗法的耐药性的一个重要因素.

结论:

了解TME的作用对于开发有效的黑色素瘤治疗方法至关重要.
针对TME有望克服治疗耐药性并改善患者的治疗结果.
对TME调节的进一步研究可能会导致黑色素瘤的新型治疗方法.

关键词:

慢性炎症是一种慢性炎症.黑色素瘤具有耐药性的树皮细胞树皮细胞有针对性的治疗.瘤微环境是一个微环境.

更多相关视频

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...